scholarly journals Histological, Immunohistological, and Ultrastructural Description of Vasculogenic Mimicry in Canine Mammary Cancer

2009 ◽  
Vol 47 (2) ◽  
pp. 265-274 ◽  
Author(s):  
M. Clemente ◽  
M. D. Pérez-Alenza ◽  
J. C. Illera ◽  
L. Peña
Keyword(s):  
Mammary Cancer ◽  
Vasculogenic Mimicry ◽  
Canine Mammary Cancer

scholarly journals Identification of tumour-associated and germ line p53 mutations in canine mammary cancer

1999 ◽  
Vol 81 (3) ◽  
pp. 409-415 ◽  
Author(s):  
N Veldhoen ◽  
J Watterson ◽  
M Brash ◽  
J Milner
Keyword(s):  
Mammary Cancer ◽  
Germ Line ◽  
P53 Mutations ◽  
Canine Mammary Cancer

scholarly journals Molecular iodine/doxorubicin neoadjuvant treatment impair invasive capacity and attenuate side effect in canine mammary cancer

2018 ◽  
Vol 14 (1) ◽  
Author(s):  
Xóchitl Zambrano-Estrada ◽  
Brianda Landaverde-Quiroz ◽  
Andrés A. Dueñas-Bocanegra ◽  
Marco A. De Paz-Campos ◽  
Gerardo Hernández-Alberto ◽  
...  
Keyword(s):  
Side Effect ◽  
Mammary Cancer ◽  
Neoadjuvant Treatment ◽  
Molecular Iodine ◽  
Canine Mammary Cancer ◽  
Invasive Capacity

scholarly journals Canine mammary cancer

2020 ◽  
Vol 51 (4) ◽  
pp. 425-439
Author(s):  
Alejandro Clavijo-Maldonado ◽  
Enio Ferreira ◽  
Carlos Vargas-Hernández ◽  
Fredy A. Rivera-Páez
Keyword(s):  
Mammary Cancer ◽  
Cellular Proliferation ◽  
Mammary Tissue ◽  
Clinical Approach ◽  
Comparative Oncology ◽  
Clinical Prognosis ◽  
Canine Mammary Cancer ◽  
Clinical Relationship ◽  
Her 2 ◽  
Poor Clinical Prognosis

Canine mammary cancer (CMC) is one of the most common neoplasms in intact females in comparison to other species. Several risk factors have been identified, including breed, genetic predisposition, age, reproductive history, hormonal influence, diet, and body condition, in addition to previous lesions to the mammary gland, such as mammary atypical hyperplasia. An understanding of the genetic markers for the disease and a clinical approach are important for establishing a specific therapy that can allow adequate patient survivorship. Overexpression of the HER-2 gene in canines and humans is associated with a poor clinical prognosis, mainly short survivorship, although the clinical relationship is not clear. The incidence of HER-2 in female dogs can range from 29.7% to 38%. However, overexpression of HER-2 is not necessarily associated with malignancy processes of the mammary tissue, although it participates in cellular proliferation. Finally, canines remain one of the most important models for comparative oncology with humans due to the great similarity in the spontaneous presentation and development of cancer, and in the high homology in the amino acid sequence.

Steroids and receptors in canine mammary cancer

Steroids ◽  
2006 ◽  
Vol 71 (7) ◽  
pp. 541-548 ◽  
Author(s):  
Juan C. Illera ◽  
Maria D. Pérez-Alenza ◽  
Ana Nieto ◽  
Maria A. Jiménez ◽  
Gema Silvan ◽  
...  
Keyword(s):  
Mammary Cancer ◽  
Canine Mammary Cancer

scholarly journals Migrastatin Analogues Inhibit Canine Mammary Cancer Cell Migration and Invasion

PLoS ONE ◽  
2013 ◽  
Vol 8 (10) ◽  
pp. e76789 ◽  
Author(s):  
Kinga Majchrzak ◽  
Daniele Lo Re ◽  
Małgorzata Gajewska ◽  
Małgorzata Bulkowska ◽  
Agata Homa ◽  
...  
Keyword(s):  
Cell Migration ◽  
Cancer Cell ◽  
Mammary Cancer ◽  
Migration And Invasion ◽  
Cancer Cell Migration ◽  
Cell Migration And Invasion ◽  
Mammary Cancer Cell ◽  
Canine Mammary Cancer

COX-2 over-expression correlates with VEGF and tumour angiogenesis in canine mammary cancer

2011 ◽  
Vol 189 (1) ◽  
pp. 77-82 ◽  
Author(s):  
Felisbina L. Queiroga ◽  
Isabel Pires ◽  
Margarida Parente ◽  
Hugo Gregório ◽  
Carlos S. Lopes
Keyword(s):  
Mammary Cancer ◽  
Tumour Angiogenesis ◽  
Over Expression ◽  
Canine Mammary Cancer ◽  
Cox 2

scholarly journals Anti-Influenza Neuraminidase Inhibitor Oseltamivir Phosphate Induces Canine Mammary Cancer Cell Aggressiveness

PLoS ONE ◽  
2015 ◽  
Vol 10 (4) ◽  
pp. e0121590 ◽  
Author(s):  
Joana T. de Oliveira ◽  
Ana L. Santos ◽  
Catarina Gomes ◽  
Rita Barros ◽  
Cláudia Ribeiro ◽  
...  
Keyword(s):  
Cancer Cell ◽  
Mammary Cancer ◽  
Neuraminidase Inhibitor ◽  
Mammary Cancer Cell ◽  
Canine Mammary Cancer ◽  
Oseltamivir Phosphate

scholarly journals Experimental Chemotherapy against Canine Mammary Cancer Xenograft in SCID Mice and Its Prediction of Clinical Effect.

2001 ◽  
Vol 63 (8) ◽  
pp. 831-836 ◽  
Author(s):  
Atsuko YAMASHITA ◽  
Kohji MARUO ◽  
Kaoru SUZUKI ◽  
Kinji SHIROTA ◽  
Kimio KOBAYASHI ◽  
...  
Keyword(s):  
Mammary Cancer ◽  
Clinical Effect ◽  
Scid Mice ◽  
Experimental Chemotherapy ◽  
Canine Mammary Cancer
Sign in / Sign up

Export Citation Format

Share Document